Friday, July 24 Company Presentations 8–Services & Others
Address /Shanghai China
Name /Yun ZHANG
Title /Assoc RDS Marketing & Communications GC
Telephone /(Work) +862124228624
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of human data science a reality. IQVIA’s approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise.
IQVIA has a long and prominent presence in Greater China, having established our first office in the region in 1997. With offices in six cities (Hong Kong, Beijing, Shanghai, Dalian, Taipei and Guangzhou) and over 2,200 employees, IQVIA has the resources, experience and site relationships necessary to help sponsors navigate the requirements, regulations and best-practices of clinical development in the region. Bridging our local expertise with our global strength, IQVIA teams in Greater China are able to tap into a robust IQVIA network and infrastructure that enables the transfer of clinical research best practices around the globe.
Our therapeutic and clinical trial experts have access to unmatched global healthcare data, advanced technology and teams that are experienced in cutting-edge analytics. Through in-depth analysis of IQVIA historical site performance metrics and real-world patient, hospital and investigator data, we are uniquely positioned to better understand how patients are treated and which sites have access to your target patient population in Greater China. This data allows us to better predict which sites will have the biggest impact on recruitment and to target those sites to accelerate start-up and recruitment timelines.
Name /Yun ZHANG